- 1、本文档共51页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
基因多态性与冠心病PPT
The concentrations of C-reactive protein in different genotype groups Gene type n CRP median Inter-quartile range CC 121 2.05 * 0.67-3.64 * CT 9 3.98 1.69-6.68 * (P0.05) The TaqⅠpolymorphism of IL-1β was associated with the concentrations of CRP in normal people The TaqⅠpolymorphism of IL-1β was not associated with with CHD CRP, The first acute-phase protein to be described, its plasma concentration increases during inflammatory states. Recently, CRP might have an important role in the pathogenesis and prediction of CHD. 1.7 CRP gene and CHD Polymorphism analysis Figure 1-1 Determination of the +1444 C/T polymorphism in the CRP gene by PCR-RFLP. Lane M:DNA Marker; Lane A:PCR product; Lane B:homozygous CC; Lane C:heterozygous CT; Polymorphism analysis Figure The chromatogram of homozygous CC Comparison of distribution of +1444 C/T genotypes and alleles between CHD group and control group Groups n Genotype Distribution(%) Allele Distribution(%) CC CT+TT C T CHD 128 114(89.1) 14(10.9) 242(94.5) 14(5.5) Control 119 107(89.9) 12(10.1) 226(95.0) 12(5.0) ?2 0.048 0.045 P 0.827 0.832 OR(95%CI) 0.913(0.404?2.063) * 0.918(0.416?2.027) △ *: genotype CC vs CT+TT;△:allele C vs T Fang Zheng Clinic Lab, Zhongnan Hospital, Wuhan University Coronary Heart Disease is still the No. 1 killer in the world. Genetics Environmental Life style The prevention of CHD is based on the control of several factors associated with a disease or clinical condition and suspected to play a pathogenetical role, defined as risk factors.The risk factors of CHD included: Age Clotting factors Sex Fibrinolytic factors Hypertension Hyperhomocysteinaemia Smoking Inflammation factors Diabetes Endothelium factor Hyperlipidaemia Nutrition factor Obesity Post-menopausal status Genetic factors Emerged CHD Risk Factors But only in 5% of hereditary CHD, the gene background was clear. In the others, each genetic factor played a minor role in occurrence and development of the disease. R
您可能关注的文档
- 围pci期的常规临床管理PPT.ppt
- 团队高效协作与执行管理模式PPT.ppt
- 团队执行力训练PPT.ppt
- 团队心理管理和管理思想发展PPT.pptx
- 围产期心肌病?心动过速心肌病?PPT.ppt
- 团队能力培训讲师PPT.ppt
- 围产期肺栓塞PPT.ppt
- 围手术期抗菌药物的预防性应用 黎沾良PPT.ppt
- 团队协作与管理PPT.ppt
- 围手术期心肌缺血与麻醉PPT.ppt
- 金融产品2024年投资策略报告:积极适应市场风格,行为金融+机器学习新发现.pdf
- 交运物流2024年度投资策略:转型十字路,峰回路又转(2023120317).pdf
- 建材行业2024年投资策略报告:板块持续磨底,重点关注需求侧复苏.pdf
- 宏观2024年投资策略报告:复苏之路.pdf
- 光储氢2024年投资策略报告:复苏在春季,需求的非线性增长曙光初现.pdf
- 公用环保2024年投资策略报告:电改持续推进,火电盈利稳定性有望进一步提升.pdf
- 房地产2024年投资策略报告:聚焦三大工程,静待需求修复.pdf
- 保险2024年投资策略报告:资产负债匹配穿越利率周期.pdf
- 政策研究2024年宏观政策与经济形势展望:共识与分歧.pdf
- 有色金属行业2024年投资策略报告:新旧需求共振&工业原料受限,构筑有色大海星辰.pdf
文档评论(0)